- Home
- WEYS vs EBS Comparison
WEYS vs EBS Comparison
Compare WEYS & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WEYS
- EBS
- Stock Information
- Founded
- WEYS 1906
- EBS 1998
- Country
- WEYS United States
- EBS United States
- Employees
- WEYS N/A
- EBS N/A
- Industry
- WEYS Apparel
- EBS Biotechnology: Pharmaceutical Preparations
- Sector
- WEYS Consumer Staples
- EBS Health Care
- Exchange
- WEYS Nasdaq
- EBS Nasdaq
- Market Cap
- WEYS 303.5M
- EBS 359.3M
- IPO Year
- WEYS N/A
- EBS 2006
- Fundamental
- Price
- WEYS $30.85
- EBS $9.23
- Analyst Decision
- WEYS
- EBS Strong Buy
- Analyst Count
- WEYS 0
- EBS 3
- Target Price
- WEYS N/A
- EBS $14.33
- AVG Volume (30 Days)
- WEYS 15.5K
- EBS 1.5M
- Earning Date
- WEYS 08-05-2025
- EBS 08-06-2025
- Dividend Yield
- WEYS 3.73%
- EBS N/A
- EPS Growth
- WEYS N/A
- EBS N/A
- EPS
- WEYS 2.69
- EBS 2.53
- Revenue
- WEYS $281,051,000.00
- EBS $851,600,000.00
- Revenue This Year
- WEYS N/A
- EBS N/A
- Revenue Next Year
- WEYS N/A
- EBS $14.20
- P/E Ratio
- WEYS $10.75
- EBS $3.65
- Revenue Growth
- WEYS N/A
- EBS N/A
- 52 Week Low
- WEYS $25.51
- EBS $4.02
- 52 Week High
- WEYS $41.05
- EBS $12.73
- Technical
- Relative Strength Index (RSI)
- WEYS 52.68
- EBS 68.42
- Support Level
- WEYS $27.83
- EBS $8.91
- Resistance Level
- WEYS $30.29
- EBS $9.43
- Average True Range (ATR)
- WEYS 1.48
- EBS 0.59
- MACD
- WEYS 0.07
- EBS 0.15
- Stochastic Oscillator
- WEYS 70.56
- EBS 88.89
About WEYS Weyco Group Inc.
Weyco Group Inc is a company, engaged in the manufacturing, designing, and distribution of footwear. The company designs and markets footwear for men, women, and children. It markets its apparel, accessories, and footwear under the brand names of Florsheim, Nunn Bush, Stacy Adams, BOGS, Rafters, and Forsake. The company organizes its business into two segments; the North American wholesale operations and the North American retail operations. The majority of the company's revenue is generated from the wholesale segment under which its products are sold to footwear, department, and specialty stores, as well as e-commerce retailers. The company has operational footprints in the United States which generates key revenue, Canada, Asia, South Africa, and Australia.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.